Prostate cancer in 2011: redefining the therapeutic landscape for CRPC
Nat Rev Urol
.
2012 Jan 17;9(2):63-4.
doi: 10.1038/nrurol.2011.235.
Authors
Carmel Pezaro
1
,
Gerhardt Attard
Affiliation
1
Section of Medicine, The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey SM2 5PT, UK.
PMID:
22249187
DOI:
10.1038/nrurol.2011.235
No abstract available
Publication types
Review
MeSH terms
Antineoplastic Agents / therapeutic use*
Combined Modality Therapy
Humans
Male
Neoplasms, Hormone-Dependent / therapy*
Orchiectomy*
Prostatic Neoplasms / therapy*
Substances
Antineoplastic Agents
Grants and funding
13239/CRUK_/Cancer Research UK/United Kingdom